Feedback clinical trials

Explore recruiting feedback clinical trials.

Recruiting feedback studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Feedback trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PPOS and CFA for elective Freeze-All ovarian stimulation cycles: a prospective cross-over study

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

TryptoBPH - Proof-of-concept study to evaluate the safety and efficacy of tryptophan in patients with BPH

Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

Fluorescence Intraoperative Surgical Margin Analysis in Head and Neck Cancer: Clinical Validation

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Perineural incobotulinumtoxin-A for Complex Regional Pain Syndrome - An open-label feasibility study (PINCom)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy of adjuvant Imatinib in patients with intermediate-risk gastrointestinal stromal tumor with a high-risk Genomic Grade Index. Multicenter, prospective, randomized study.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase I/II, open-ended, adaptative, open label dose escalation and expansion clinical trial to evaluate the efficacy and safety of unilateral intracochlear injection of SENS-501 using an injection system in children with severe to profound hearing loss due to Otoferlin gene mutations

Italy, France, Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Feedback trials by city

Feedback in Toronto Feedback in Vancouver Feedback in Montreal Feedback in Calgary Feedback in Edmonton Feedback in Ottawa Feedback in Winnipeg Feedback in Quebec City Feedback in Hamilton Feedback in Kitchener Feedback in London Feedback in Halifax Feedback in New York Feedback in Los Angeles Feedback in Chicago Feedback in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease